Inventor
BUJ BELLO ANA MARIA
FR11 patents
⚠️ This page may combine multiple inventors who share the name “BUJ BELLO ANA MARIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV WAKE FOREST HEALTH SCIENCES
6 patentsUS9895426B2Feb 20, 2018
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
UNIV WAKE FOREST HEALTH SCIENCES3 citations81
US9839677B2Dec 12, 2017
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
UNIV WAKE FOREST HEALTH SCIENCES3 citations81
US9415120B2Aug 16, 2016
Systemic gene replacement therapy for treatment of X-linked MyoTubular Myopathy (XLMTM)
UNIV WAKE FOREST HEALTH SCIENCES5 citations81
US8957044B2Feb 17, 2015
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
UNIV WAKE FOREST HEALTH SCIENCES6 citations81
US11564977B2Jan 31, 2023
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
UNIV WAKE FOREST HEALTH SCIENCES2 citations70
US12178856B2Dec 31, 2024
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
UNIV WAKE FOREST HEALTH SCIENCES0 citations60
GENETHON
5 patentsUS11819478B2Nov 21, 2023
Selective gene therapy expression system
GENETHON0 citations60
US11499154B2Nov 15, 2022
Antisense targeting dynamin 2 and use for the treatment of centronuclear myopathies and neuropathies
GENETHON0 citations60
US11104897B2Aug 31, 2021
Compositions and methods for the treatment of nucleotide repeat expansion disorders
GENETHON0 citations53
US9981049B2May 29, 2018
Selective gene therapy expression system
GENETHON1 citations50
US11427824B2Aug 30, 2022
Compositions and methods for the treatment of myotonic dystrophy
GENETHON0 citations42